Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.7
16.49
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Zentalis Pharmaceuticals Inc
Wall Street
Price Targets
ZNTL Price Targets Summary
Zentalis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ZNTL
is 9.69 USD
with a low forecast of 4.04 USD and a high forecast of 21 USD.
ZNTL Last Price Targets
Zentalis Pharmaceuticals Inc
The latest public price target was made on Jun 18, 2024 by
Robert Driscoll
from
Wedbush
,
who expects
ZNTL
stock to
rise by 33%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Robert Driscoll
Wedbush
|
4
USD
Upside 33% |
6 months ago
Jun 18, 2024
|
Wedbush downgrades Zentalis to Underperform on unclear azeno path forward
TheFly
|
Matthew Harrison
Morgan Stanley
|
8
USD
Upside 167% |
6 months ago
Jun 18, 2024
|
Morgan Stanley Downgrades Zentalis Pharmaceuticals (ZNTL) to Equalweight
StreetInsider
|
Bradley Canino
Stifel Nicolaus
|
10
USD
Upside 233% |
6 months ago
Jun 18, 2024
|
Zentalis price target lowered to $10 from $32 at Stifel
TheFly
|
Akash Tewari
Jefferies
|
6
USD
Upside 100% |
6 months ago
Jun 18, 2024
|
Zentalis downgraded to Hold from Buy at Jefferies
TheFly
|
|
Bradley Canino
Stifel Nicolaus
|
32
USD
Upside 967% |
7 months ago
May 7, 2024
|
Zentalis Pharmaceuticals (ZNTL) PT Lowered to $32 at Stifel
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ZNTL's stock price target?
Price Target
9.69
USD
According to Wall Street analysts, the average 1-year price target for
ZNTL
is 9.69 USD
with a low forecast of 4.04 USD and a high forecast of 21 USD.
You don't have any saved screeners yet
